A large observational study published in Nature Communications (Wang et al., 2024) followed 83,825 patients with obesity and found that GLP-1 receptor agonists, including semaglutide, were associated with a substantially lower risk of alcohol use disorder (AUD) incidence and recurrence
Sections were scanned and processed using a 3D-reconstruction program
circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis
Total GLP-1 ELISA Total GLP-1 ELISA (10-1278-01) Kit format: 1 x 96 wells Measurement range: 0.9 - 940 pmol/L (2.8 - 2940 pg/mL) 100% specificity to the predominating isoform, GLP-1 (9-36) amide High sensitivity Validated according to CLSI/FDA/EMA Controls available: 10-1287-01 Description Mercodia Total GLP-1 ELISA The Mercodia Total GLP-1 ELISA provides a chemiluminescent method for the quantitative determination of amidated glucagon-like-peptide-1 (GLP-1) in human plasma and serum samples
1985, EP 0158194- Lee SY: High cell-density culture of Escherichia coli
GLP-1 receptor agonists and multi-organ risk: A retrospective cohort study